TVGNW Tevogen Inc. - Warrant

0.0650USD+7.08%Mkt Cap: —P/E: —

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, wh…

Key Statistics

Company
Market Cap—
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.28M USD
Revenue/Share—
Last Price0.0650 USD
Fiscal Year End—
MR Quarter—
Employees18
CountryUS
SectorFinancial Services
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.01
EPS (TTM)—
EPS (Forward)—
52W Range
0.033976% of range0.0750
52W High0.0750 USD
52W Low0.0339 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE319.08%
ROA-599.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.33M USD
CapEx (TTM)64.44K USD
FCF Margin—
FCF Yield—
Net Debt8.36M USD
Net Debt/EBITDA-0.39
Balance Sheet
Debt/Equity-0.91
Current Ratio0.33
Quick Ratio0.20
Book Value/Sh-4.16 USD
Cash/Share0.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float841.62K
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta0.20
S&P 52W Chg15.78%
Avg Vol (30d)329.56K
Avg Vol (10d)—
Technical Indicators
RSI (14)66.0
MACD0.0040
MACD Signal0.0034
MACD Hist.+0.0006
BB Upper0.0627 USD
BB Middle0.0545 USD
BB Lower0.0463 USD
BB Width30.09%
ATR (14)0.0096 USD
Vol Ratio (20d)0.75x